German measles, also known as rubella, is a viral infection caused by the rubella virus. It is characterized by a distinctive red rash that typically starts on the face and spreads to the rest of the body. Rubella is generally a mild illness, but it poses significant risks to pregnant women, as infection during early pregnancy can lead to congenital rubella syndrome (CRS) in the developing fetus. CRS can result in severe birth defects, including hearing impairment, heart abnormalities, and developmental delays. The symptoms of rubella include a low-grade fever, swollen lymph nodes, and a rash that lasts for a few days. The virus is highly contagious and primarily spreads through respiratory droplets from an infected person. Vaccination, usually administered as part of the MMR (measles, mumps, and rubella) vaccine, has been instrumental in reducing the incidence of rubella and preventing its associated complications. Public health efforts, including widespread vaccination campaigns, have made significant strides in controlling rubella globally. The goal is to achieve high vaccination coverage to establish herd immunity and protect vulnerable populations, particularly pregnant women and their unborn children.
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation